Eight private company boards have been recognized with the 2025 Private Company Boards of the Year awards by MLR Media for ...

Email: [email protected] Eight private company boards have been honored with Private Company Boards of the Year awards for their business governance excellence by MLR Media. The awards will ...

March 24, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported ...

Shares of NASDAQ:BRNS opened at $0.99 on Friday. Barinthus Biotherapeutics has a fifty-two week low of $0.80 and a fifty-two week high of $4.16. The firm has a 50-day simple moving average of $1. ...

Credit: PowerUp/Shutterstock. Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment. The partnership will leverage ...

Roche has forged a mul­ti­year part­ner­ship with Ox­ford Bio­Ther­a­peu­tics to find new tar­gets for an­ti­body-based can­cer treat­ments with an up­front pay­ment of $36 mil ...

Roche has secured its third antibody-drug conjugate pact of the year, this time agreeing to hand $36 million in upfront payments to Oxford BioTherapeutics. The agreement will also see U.K.-based ...

Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets. Roche has inked an immuno-oncology partnership with ...

In this article, we are going to take a look at where Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) stands against other most oversold penny stocks to buy according to analysts. In February 2025 ...

Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics Fiscal Year 2024 Financial and Business Results Conference Call. As a reminder, this conference call is being recorded.

Protalix BioTherapeutics Inc. earnings at a glance (GAAP) : -Earnings: $2.93 Mln. vs. $8.31 Mln. last year. -EPS: $0.04 vs. $0.09 last year. -Revenue: $53.40 Mln vs. $65.49 Mln last year.